tirzepatide/pyridoxine compound Tirzepatide 30mg (10mg/mL + B6 10mg/mL) (3mL Vial) COMPOUNDED TIRZEPATIDE

Conclusion Due to the rise in GLP-1RA prescribing for weight loss, we recommend clinicians be vigilant regarding unremitting nausea/vomiting that occurs with lurasidone and possibly other second-generation antipsychotics upon initiation of GLP-1RAs

Mechanism of Action Enhances glucose-dependent insulin secretion Suppresses glucagon release Delays gastric emptying Promotes satiety via central appetite regulation Pharmacokinetics Route: Subcutaneous (once weekly) Half-life: ~1 week Metabolism: Proteolytic degradation Excretion: Urine and feces Clinical Benefits HbA1c reduction of ~11.5% Significant weight loss (515%) Proven cardiovascular protection Minimal risk of hypoglycemia when used alone Adverse Effects Common: Nausea, vomiting, diarrhea Rare: Pancreatitis, gallbladder disease Contraindicated in medullary thyroid carcinoma / MEN-2 The Bigger Picture -The transition of semaglutide from a high-cost, premium therapy to an affordable mass drug represents a paradigm shift

Questions to Ask Your Doctor or Practitioner Working closely with a healthcare provider can help you make the most of your GLP-1 journey

Include naturally electrolyte-rich foods: coconut water, bone broth, seaweed snacks, leafy greens, and unsalted nuts

Book your consultation today and take the next step toward feeling great in your skin

To find a shingles vaccine provider near you and schedule an appointment, use this shingles vaccine locator tool